vs

Side-by-side financial comparison of GEN Restaurant Group, Inc. (GENK) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $49.7M, roughly 1.7× GEN Restaurant Group, Inc.). GEN Restaurant Group, Inc. runs the higher net margin — -3.8% vs -38.1%, a 34.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -9.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -1.0%).

Gen Korean BBQ is an American chain of all-you-can-eat Korean barbecue restaurants mainly concentrated around the Western U.S. It opened in 2011, and has since grown to 43 locations as of 2024.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GENK vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.7× larger
PRCT
$83.1M
$49.7M
GENK
Growing faster (revenue YoY)
PRCT
PRCT
+29.2% gap
PRCT
20.2%
-9.0%
GENK
Higher net margin
GENK
GENK
34.2% more per $
GENK
-3.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-1.0%
GENK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENK
GENK
PRCT
PRCT
Revenue
$49.7M
$83.1M
Net Profit
$-1.9M
$-31.6M
Gross Margin
64.9%
Operating Margin
-24.5%
-4.1%
Net Margin
-3.8%
-38.1%
Revenue YoY
-9.0%
20.2%
Net Profit YoY
-821.4%
-27.9%
EPS (diluted)
$-0.37
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENK
GENK
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$49.7M
$76.4M
Q3 25
$50.4M
$83.3M
Q2 25
$55.0M
$79.2M
Q1 25
$57.3M
$69.2M
Q4 24
$54.7M
$68.2M
Q3 24
$49.1M
$58.4M
Q2 24
$53.9M
$53.4M
Net Profit
GENK
GENK
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-1.9M
$-29.8M
Q3 25
$-566.0K
$-21.4M
Q2 25
$-261.0K
$-19.6M
Q1 25
$-301.0K
$-24.7M
Q4 24
$-206.0K
$-18.9M
Q3 24
$25.0K
$-21.0M
Q2 24
$277.0K
$-25.6M
Gross Margin
GENK
GENK
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
GENK
GENK
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-24.5%
-40.6%
Q3 25
-7.4%
-27.8%
Q2 25
-3.4%
-28.0%
Q1 25
-3.8%
-39.7%
Q4 24
-2.4%
-28.9%
Q3 24
0.2%
-38.4%
Q2 24
3.0%
-50.3%
Net Margin
GENK
GENK
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-3.8%
-39.1%
Q3 25
-1.1%
-25.7%
Q2 25
-0.5%
-24.7%
Q1 25
-0.5%
-35.8%
Q4 24
-0.4%
-27.6%
Q3 24
0.1%
-35.9%
Q2 24
0.5%
-48.0%
EPS (diluted)
GENK
GENK
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.37
$-0.54
Q3 25
$-0.11
$-0.38
Q2 25
$-0.05
$-0.35
Q1 25
$-0.06
$-0.45
Q4 24
$-0.05
$-0.34
Q3 24
$0.01
$-0.40
Q2 24
$0.06
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENK
GENK
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$2.8M
$245.6M
Total DebtLower is stronger
$13.6M
$51.7M
Stockholders' EquityBook value
$26.5M
$347.7M
Total Assets
$259.9M
$487.1M
Debt / EquityLower = less leverage
0.51×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENK
GENK
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$2.8M
$286.5M
Q3 25
$4.8M
$294.3M
Q2 25
$9.6M
$302.7M
Q1 25
$15.4M
$316.2M
Q4 24
$23.7M
$333.7M
Q3 24
$22.1M
$196.8M
Q2 24
$29.2M
$214.1M
Total Debt
GENK
GENK
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$13.6M
$51.6M
Q3 25
$10.8M
$51.6M
Q2 25
$7.8M
$51.5M
Q1 25
$6.5M
$51.5M
Q4 24
$6.9M
$51.5M
Q3 24
$7.2M
$51.4M
Q2 24
$7.6M
$51.4M
Stockholders' Equity
GENK
GENK
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$26.5M
$365.9M
Q3 25
$38.1M
$380.3M
Q2 25
$41.0M
$385.8M
Q1 25
$42.8M
$389.2M
Q4 24
$44.1M
$402.2M
Q3 24
$46.5M
$241.2M
Q2 24
$45.9M
$251.8M
Total Assets
GENK
GENK
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$259.9M
$508.1M
Q3 25
$245.5M
$511.5M
Q2 25
$246.3M
$513.1M
Q1 25
$232.4M
$519.4M
Q4 24
$240.4M
$534.0M
Q3 24
$225.7M
$374.1M
Q2 24
$218.8M
$374.4M
Debt / Equity
GENK
GENK
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.51×
0.14×
Q3 25
0.28×
0.14×
Q2 25
0.19×
0.13×
Q1 25
0.15×
0.13×
Q4 24
0.16×
0.13×
Q3 24
0.16×
0.21×
Q2 24
0.17×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENK
GENK
PRCT
PRCT
Operating Cash FlowLast quarter
$-426.0K
Free Cash FlowOCF − Capex
$-5.6M
FCF MarginFCF / Revenue
-11.3%
Capex IntensityCapex / Revenue
10.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-24.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENK
GENK
PRCT
PRCT
Q1 26
Q4 25
$-426.0K
$-10.3M
Q3 25
$-1.6M
$-6.6M
Q2 25
$3.3M
$-15.0M
Q1 25
$2.2M
$-17.0M
Q4 24
$7.3M
$-32.4M
Q3 24
$1.4M
$-18.8M
Q2 24
$5.6M
$-15.7M
Free Cash Flow
GENK
GENK
PRCT
PRCT
Q1 26
Q4 25
$-5.6M
$-12.2M
Q3 25
$-7.7M
$-9.5M
Q2 25
$-6.3M
$-17.8M
Q1 25
$-4.7M
$-18.8M
Q4 24
$165.0K
$-33.6M
Q3 24
$-6.8M
$-19.0M
Q2 24
$1.2M
$-16.8M
FCF Margin
GENK
GENK
PRCT
PRCT
Q1 26
Q4 25
-11.3%
-15.9%
Q3 25
-15.3%
-11.4%
Q2 25
-11.5%
-22.5%
Q1 25
-8.2%
-27.2%
Q4 24
0.3%
-49.2%
Q3 24
-13.9%
-32.6%
Q2 24
2.3%
-31.4%
Capex Intensity
GENK
GENK
PRCT
PRCT
Q1 26
Q4 25
10.5%
2.4%
Q3 25
12.0%
3.4%
Q2 25
17.5%
3.5%
Q1 25
11.9%
2.7%
Q4 24
13.1%
1.7%
Q3 24
16.9%
0.4%
Q2 24
8.0%
2.0%
Cash Conversion
GENK
GENK
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
57.96×
Q2 24
20.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENK
GENK

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons